Oral Consumption of Cannabidiol During Pregnancy Alters Behavior in Mouse Offspring
| Journal | Cannabis and cannabinoid research |
| Study Type | Clinical Study |
| Population | Human participants |
This preclinical study addresses a critical gap in prenatal cannabis safety data, as CBD use during pregnancy is increasing despite limited developmental safety research. The findings suggest even moderate CBD doses may cause sex-specific neurodevelopmental effects in offspring.
Researchers administered 10 mg/kg/day CBD orally to pregnant mice from embryonic day 5 through birth and assessed offspring behavior and brain physiology. Male offspring showed increased thermal pain sensitivity, while female offspring demonstrated cognitive impairment and reduced prefrontal cortex excitability. This mouse study used a dose roughly equivalent to moderate human CBD consumption and found concerning neurodevelopmental effects that varied by offspring sex. The study is limited by its preclinical nature and single-dose design.
“This adds to mounting preclinical evidence that CBD crosses the placenta and may disrupt fetal brain development, even at doses many would consider therapeutic. While mouse studies don’t directly translate to humans, the neurodevelopmental concerns are serious enough to warrant extreme caution.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
Is CBD safe to use during pregnancy for nausea and anxiety?
This study found that even moderate doses of CBD (10 mg/kg/day) during pregnancy caused neurodevelopmental changes in mouse offspring, including increased pain sensitivity in males and cognitive impairment in females. While many pregnant people use CBD for symptom relief, this preclinical evidence suggests potential risks to fetal brain development that warrant caution.
What dose of CBD was studied and how does it relate to human use?
The study used 10 mg/kg/day of oral CBD, which is considered a lower dose compared to previous high-dose studies that showed neurodevelopmental disruption. This dose may be more comparable to therapeutic doses used by pregnant individuals for managing symptoms like nausea, anxiety, and pain.
Are there sex-specific effects of prenatal CBD exposure?
Yes, the study found different effects based on offspring sex: male mice showed increased thermal pain sensitivity, while female mice experienced cognitive impairment and reduced prefrontal cortex excitability. These sex-specific differences suggest that CBD’s developmental effects may vary depending on fetal sex.
Does CBD cross the placenta and affect the developing brain?
According to this research, CBD crosses the placenta and enters the fetal brain where it can affect multiple targets important for brain development. The study demonstrates that prenatal CBD exposure alters prefrontal cortex physiology and leads to measurable behavioral changes in offspring.
Should healthcare providers recommend CBD during pregnancy based on this evidence?
This preclinical study adds to growing evidence suggesting potential neurodevelopmental risks from prenatal CBD exposure, even at moderate doses. Healthcare providers should discuss these potential risks with patients and consider alternative treatments for pregnancy-related symptoms until more definitive human safety data is available.
